Genetic variation in the interleukin 10 gene promoter and systemic lupus erythematosus

Journal of Rheumatology

Volumn 24, Issue 12, 1997, Pages 2314-2317

  Lazarus, Mark ^a   Hajeer, Ali H ^b   Turner, David ^c   Sinnott, Paul ^c   Worthington, Jane ^b   Ollier, William E R ^b   Hutchinson, Ian V ^a,d  

^a Immunology Research Group   (United Kingdom)

^b ARC ERU ^*

^c ST MARY S HOSPITAL   (United States)

^d UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

Interleukin 10; Polymorphisms; Promoter; SLE

Indexed keywords

ADENINE; AUTOANTIBODY; CYTOSINE; DNA; GUANINE; INTERLEUKIN 10; THYMINE;

ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; CLINICAL FEATURE; CONTROLLED STUDY; DNA POLYMORPHISM; FEMALE; GENE FREQUENCY; GENETIC VARIABILITY; GENOTYPE; HAPLOTYPE; HUMAN; KIDNEY DISEASE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROMOTER REGION; SYSTEMIC LUPUS ERYTHEMATOSUS;

ADOLESCENT; ADULT; AGED; ALLELES; AUTOANTIBODIES; CHILD; FEMALE; GENE EXPRESSION REGULATION; GENE FREQUENCY; HAPLOTYPES; HETEROZYGOTE; HOMOZYGOTE; HUMANS; INTERLEUKIN-10; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; PROMOTER REGIONS (GENETICS); VARIATION (GENETICS);

EID: 0031453916     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Steinberg AD, Klinman DM: Pathogenesis of systemic lupus erythematosus. Rheum Dis Clin North Am 1988;14:25-41.
2. Becher TM, Lizzio EF, Mercant LP, et al: Increased multiclonal antibody-forming cell activation in the peripheral blood of patients with SLE. Int Arch Allerg Appl Immunol 1981;66:293-8.
3. Blaese RM, Grayson J, Steinberg AD: Elevated immunoglobulin secreting cells in the blood of patients with active systemic lupus erythematosus: Correlation of laboratory and clinical assessment of disease activity. Am J Med 1980;69:345-50.
4. Mills JA: Systemic lupus erythematosus. N Engl J Med 1994;330:1871-9.
5. Mosmann TR, Coffman RL: Th1 and Th2 cells: Different patterns of lymphokine secretion lead to different functional properties. Ann Rev Immunol 1989;7:145-73.
6. Levey Y, Brouet JC: Interleukin-10 prevents the spontaneous death of germinal center B cells by the induction of the bcl-2 protein. J Clin Invest 1994;93:424-8.
7. Strasser A, Whittingham S, Vaux DL, et al: Enforced bcl-2 expression in B lymphoid cells prolongs antibody responses and elicits autoimmune disease. Proc Natl Acad Sci USA 1991;88:8661-5.
8. Richard-Patin Y, Alcocer-Varela J, Llorente L: High levels of TH2 cytokine gene expression in systemic lupus erythematosus. Rev Invest Clin 1995;47:267-72.
9. AlJanadi M, AlBalla S, AlDalaan A, Raziuddin S: Cytokine profile in systemic lupus erythematosus, rheumatoid arthritis, and other rheumatic diseases. J Clin Immunol 1993;13:58-67.
10. Houssiau FA, Lefebvre C, Vanden-Berghe M, et al: Serum interleukin 10 titers in systemic lupus erythematosus reflect disease activity. Lupus 1995;4:393-5.
11. Hagiwara E, Gourley MF, Lee S, Klinman DM: Disease severity in patients with systemic lupus erythematosus correlates with an increased ratio of interleukin-10: Interferon-secreting cells in the peripheral blood. Arthritis Rheum 1996;39:379-85.
12. Turner DM, Williams DM, Sankaran D, et al: An investigation of polymorphism in the interleukin-10 gene promoter. Eur J Immunogen 1997;24:1-8.
13. Kube D, Platzer C, von Knethen A, et al: Isolation of the human IL-10 promoter. Characterisation of the promoter activity in Burkitt lymphomacell lines. Cytokine 1995;7:1-7.
14. Tan EM, Cohen AS, Fries JF, et al: The 1982 ARA criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982;25:1271-7.
15. Lahita RG: Sex and age in systemic lupus erythematosus. In: Lahita RG, ed. Systemic Lupus Erythematosus. New York: Churchill Livingstone, 1988.
16. Jungers P, Dougados M, Pelissier C, et al: Influence of oral contraceptive therapy on the activity of systemic lupus erythematosus. Arthritis Rheum 1982;25:618-23.
17. Briggs DC, Senaldi G, Isenberg DA, et al: Influence of C4 null alleles on C4 activation in systemic lupus erythematosus. Ann Rheum Dis 1991;50:251-4.
18. Arnett FC, Reveille JD: Genetics of systemic lupus erythematosus. Rheum Dis Clin North Am 1992;18:865-92.
19. Jacob CO, Fronek Z, Lewis GD, et al: Heritable major histocompatibility complex class II-associated differences in production of tumor necrosis factor alpha: Relevance to genetic predisposition to systemic lupus erythematosus. Proc Natl Acad Sci USA 1990;87:1233-7.
20. Ollier W, Davies E, Snowden N, et al: Homozygosity for glutathione S-transferase GSTM1 null alleles is associated with the Ro+/La-autoantibody profile in SLE. Arthritis Rheum 1996;39:1763-4.
21. Caux C, Massacrier B, Vanbervliet C, et al: Interleukin 10 inhibits T cell alloreaction induced by human dendritic cells. Int Immunol 1994;6:1177-85.
22. Ding I, Linsley PS, Huang LY, et al: IL-10 inhibits macrophage costimulatory activity by selectively inhibiting the upregulation of B7 expression. J Immunol 1993;151:1224-34.
23. Romagnani S: Human Th1 and Th2 subsets: Doubt no more. Immunology Today 1991;12:265-51.